Scientific News
When we eat, we are not adding energy to a furnace. We are running a programme. And like any programme, the outcome depends entirely on the operating system that interprets…
Pregnancy: how dysbiosis may affect placentation, maternal immunity, and the risk of neonatal sepsis
Maria Rescigno (Humanitas University, Rozzano, Milan) discusses the role of dysbiosis during pregnancy and the perinatal period, outlining two potential clinical trajectories.
Dietary protein influences V. cholerae growth, metabolism, virulence, and competition with gut microbes.
Some bacteria common in dog owners, particularly Streptococcus strains, were linked to fewer behavioral and attention problems.
Video, Gastroenterology
Sponsored by
How postbiotics are reshaping dietary supplements and pharma: key insights from Humiome® Post LB.
Francesco Franceschi from Policlinico Universitario A. Gemelli IRCCS (Roma) focuses on bacterial translocation across a compromised intestinal barrier as a plausible pathway contributing to sepsis.
Lantibiotic-producing gut bacteria can prolong gut imbalance and increase susceptibility to dangerous infections after antibiotics.
MTB and aerolysin drive gut inflammation in ulcerative colitis.
William Fusco, gastroenterologist at Policlinico Universitario Agostino Gemelli, highlighted a recently published pilot study on post-infectious irritable bowel syndrome (IBS) framed within microbial precision medicine and biomarker-driven care.
Nutrient competition provides a predictive framework to anticipate and potentially mitigate drug side effects on the gut microbiota.
The interaction between gut microbes, the amino acid leucine and sIL-6R determines a person’s responsiveness to exercise.
Camille Bello, Communication and Membership Manager at Pharmabiotics Research Institute, underscores the conference’s regulatory focus and PRI’s role in guiding microbiome innovations through complex approval pathways.
Celine Druart, Executive Director at Pharmabiotic Research Institute, discusses the 10th Pharmabiotics Conference in Brussels, from microbiome biomarkers and One Health to key regulatory developments shaping live biotherapeutic products.
Veronica Ojetti, gastroenterologist at San Carlo di Nancy Hospital (Italy), presents findings from a single-center pilot study assessing the effects of L. reuteri LMG P-27481 on the gut microbiota and…
Future studies should have clearly defined hypotheses, adequate sample size, standardized protocols, and replication using multiple independent approaches.
Changes in gut bacteria raise a child’s chances of developing IBD later in life, offering clues to why the conditions sometimes runs in families.
Francesca Ponziani from Gemelli University Hospital (Italy) highlights how the gut microbiota can become a clinical tool for identifying and stratifying patients, clarifying pathogenic mechanisms, and opening up new therapeutic…
Certain harmful microbes in the mouth appear to promote cancer development, while others might help protect against it.
Researchers set up a clinical trial to study how glucocorticoids affected the gut microbiota, metabolism, and immunity in healthy young men.
Federica Facciotti, from University of Milano Bicocca, focuses on how the gut microbiota interacts with immune activation, shaping both chronic inflammatory intestinal disorders and oncology, particularly colorectal cancer.
